Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Autolus Therapeutics PLC Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 67,979 shares of AUTL stock, worth $155,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,979
Previous 74,398
8.63%
Holding current value
$155,671
Previous $258,000
4.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
104Shares Held
163MCall Options Held
2.8KPut Options Held
13.4K-
Wellington Management Group LLP Boston, MA24.2MShares$55.5 Million0.02% of portfolio
-
Blackstone Inc New York, NY20.5MShares$46.9 Million0.35% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X018.6MShares$42.5 Million83.42% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$35 Million2.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$28.3 Million0.67% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $208M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...